Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Asad Bashey

Showing results (81-90 of 128) with videos related to

Pageof 13
Sort By:
Transplantation and Cellular Therapy|November 15, 2021
Impact of Induction Therapy with VRD versus VCD on Outcomes in Patients with Multiple Myeloma in Partial Response or Better Undergoing Upfront Autologous Stem Cell TransplantationSurbhi Sidana, Shaji Kumar, Raphael Fraser, et al.
Blood|June 2, 2020
A multicenter phase 1 study of nivolumab for relapsed hematologic malignancies after allogeneic transplantationMatthew S Davids, Haesook T Kim, Caitlin Costello, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 11, 2020
Optimal Donor for African Americans with Hematologic Malignancy: HLA-Haploidentical Relative or Umbilical Cord Blood TransplantScott R Solomon, Andrew St Martin, Mei-Jie Zhang, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 23, 2008
Comparable outcomes in nonsecretory and secretory multiple myeloma after autologous stem cell transplantationShaji Kumar, Waleska S Pérez, Mei-Jie Zhang, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 23, 2008
Comparison of twin and autologous transplants for multiple myelomaAsad Bashey, Waleska S Pérez, Mei-Jie Zhang, et al.
Blood|November 1, 2021
HLA informs risk predictions after haploidentical stem cell transplantation with posttransplantation cyclophosphamideEphraim J Fuchs, Shannon R McCurdy, Scott R Solomon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 8, 2020
Nonmyeloablative Alternative Donor Transplantation for Hodgkin and Non-Hodgkin Lymphoma: From the LWP-EBMT, Eurocord, and CIBMTRGiancarlo Fatobene, Vanderson Rocha, Andrew St Martin, et al.
JCO Oncology Practice|October 30, 2020
Comanagement Strategy Between Academic Institutions and Community Practices to Reduce Induction Mortality in Acute Promyelocytic LeukemiaAnand P Jillella, Martha L Arellano, Manila Gaddh, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 30, 2004
Autologous transplantation for diffuse aggressive non-Hodgkin lymphoma in first relapse or second remissionJulie M Vose, Douglas J Rizzo, Jing Tao-Wu, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 3, 2009
Outcome of transplantation for myelofibrosisKaren K Ballen, Smriti Shrestha, Kathleen A Sobocinski, et al.
Pageof 13

Showing results (81-90 of 128) with videos related to

Sort By:
Pageof 13
Transplantation and Cellular Therapy|November 15, 2021
Impact of Induction Therapy with VRD versus VCD on Outcomes in Patients with Multiple Myeloma in Partial Response or Better Undergoing Upfront Autologous Stem Cell TransplantationSurbhi Sidana, Shaji Kumar, Raphael Fraser, et al.
Blood|June 2, 2020
A multicenter phase 1 study of nivolumab for relapsed hematologic malignancies after allogeneic transplantationMatthew S Davids, Haesook T Kim, Caitlin Costello, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 11, 2020
Optimal Donor for African Americans with Hematologic Malignancy: HLA-Haploidentical Relative or Umbilical Cord Blood TransplantScott R Solomon, Andrew St Martin, Mei-Jie Zhang, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 23, 2008
Comparable outcomes in nonsecretory and secretory multiple myeloma after autologous stem cell transplantationShaji Kumar, Waleska S Pérez, Mei-Jie Zhang, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 23, 2008
Comparison of twin and autologous transplants for multiple myelomaAsad Bashey, Waleska S Pérez, Mei-Jie Zhang, et al.
Blood|November 1, 2021
HLA informs risk predictions after haploidentical stem cell transplantation with posttransplantation cyclophosphamideEphraim J Fuchs, Shannon R McCurdy, Scott R Solomon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 8, 2020
Nonmyeloablative Alternative Donor Transplantation for Hodgkin and Non-Hodgkin Lymphoma: From the LWP-EBMT, Eurocord, and CIBMTRGiancarlo Fatobene, Vanderson Rocha, Andrew St Martin, et al.
JCO Oncology Practice|October 30, 2020
Comanagement Strategy Between Academic Institutions and Community Practices to Reduce Induction Mortality in Acute Promyelocytic LeukemiaAnand P Jillella, Martha L Arellano, Manila Gaddh, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 30, 2004
Autologous transplantation for diffuse aggressive non-Hodgkin lymphoma in first relapse or second remissionJulie M Vose, Douglas J Rizzo, Jing Tao-Wu, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 3, 2009
Outcome of transplantation for myelofibrosisKaren K Ballen, Smriti Shrestha, Kathleen A Sobocinski, et al.
Pageof 13